🇺🇸 FDA
Pipeline program

linvoseltamab

R5458-668-ALG-2219

Phase 1 small_molecule active

Quick answer

linvoseltamab for Food Allergy is a Phase 1 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Food Allergy
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials